Renalytix plc
RNLXY· OTC
Quarterly figures for Renalytix plc, with source filings when available.
10 quarters. Jun 30, 2018 to Sep 30, 2024. USD.
Renalytix plc has filed its 10-Q within 45 to 50 days of period end across its last 4 quarters. The 10-K runs 90 to 92 days.
Renalytix plc · CIK 1811115 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q1 2025 | Sep 30, 2024 | Oct 1, 2024 · after-hours | Nov 19, 2024 | 50 d | 10-Q | $522.00K | +13.7% | -$0.04 | |
| FY 2024 | |||||||||
| Q4 2024derived | Jun 30, 2024 | — | Sep 30, 2024 | 92 d | 10-K | $586.00K | — | — | |
| Q3 2024 | Mar 31, 2024 | May 15, 2024 · pre-market | May 15, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Jun 30, 2023 | Sep 28, 2023 · pre-market | Sep 28, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2023 | Mar 31, 2023 | — | — | — | — | $724.00K | — | ||
| FY 2018 | |||||||||
| Q4 2018 | Jun 30, 2018 | — | — | — | — | — | — | -$0.03 | |
| 45 d |
| 10-Q |
| $535.00K |
| −26.1% |
| -$0.08 |
| Q2 2024 | Dec 31, 2023 | — | Feb 14, 2024 | 45 d | 10-Q | $709.00K | −40.5% | -$0.09 |
|---|
| Q1 2024 | Sep 30, 2023 | Nov 14, 2023 · pre-market | Nov 14, 2023 | 45 d | 10-Q | $459.00K | −52.6% | -$0.11 |
|---|
| -$0.14 |
| Q2 2023 | Dec 31, 2022 | — | — | — | — | $1.19M | — | -$0.14 |
|---|
| Q1 2023 | Sep 30, 2022 | — | — | — | — | $969.00K | — | -$0.16 |
|---|